Records containing: Lung Cancer
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-11-10Real-Time Image Guided Lymphatic Mapping and Nodal Targeting in Lung Cancer
-
CLINICAL_TRIALS study record update · 2025-11-05Biodistribution and Pharmacokinetic Study of the Positron Emission Tomography (PET) Radiopharmaceutical [18F]-C-SNAT4
-
CLINICAL_TRIALS study record update · 2025-11-04Determination and Validation of Lung EpiCheck®: A Multianalyte Assay for Lung Cancer Prediction. A Case-Control Study
-
CLINICAL_TRIALS study record update · 2025-10-24Detection of Genetic Markers of Lung Cancer Initiation and Progression
-
CLINICAL_TRIALS study record update · 2025-10-20A Phase II Study of Neoadjuvant Sotorasib in Combination With Cisplatin or Carboplatin and Pemetrexed for Surgically Resectable Stage IIA-IIIB Non-Squamous Non-Small Cell Lung Cancer With a KRAS p.G12C Mutation
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-10-20Phase 2 Trial of Neoadjuvant Nivolumab + Platinum-based Chemotherapy + Certolizumab in Patients With Resectable Stages II-III Lung Cancers
-
CLINICAL_TRIALS study record update · 2025-10-16University of North Carolina Pleural Fluid Registry
-
CLINICAL_TRIALS study record update · 2025-10-15The Efficacy and Safety of Osimertinib With Platinum Plus Pemetrexed Chemotherapy as First-line Treatment in Advanced Non-small Cell Lung Cancer Patients With Uncommon Epidermal Growth Factor Receptor Mutations: A phase2, Open Label, Single Arm, Multicenter, Exploratory Study
-
CLINICAL_TRIALS study record update · 2025-10-14Health Opportunities and Promoters of Equitable Screening for Lung Cancer (HOPES for Lung Cancer)
-
CLINICAL_TRIALS study record update · 2025-10-14Identification of Prognostic Biomarkers for Progression of Invasive Squamous Cell Carcinoma
-
CLINICAL_TRIALS study record update · 2025-10-10Prolonged Air Leak (PAL) Autologous Blood Patch Intervention Trial
-
CLINICAL_TRIALS study record update · 2025-10-09A Multicenter, Randomized, Open-Label, Phase 1b/2 Trial Of Valemetostat Tosylate Plus Pembrolizumab Vs Pembrolizumab Alone in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Whose Tumors Express PD-L1 With Tumor Proportion Score ≥50% Without Actionable Genomic Alterations
-
CLINICAL_TRIALS study record update · 2025-10-08A Phase I/II Clinical Trial of Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen Mesothelin
-
CLINICAL_TRIALS study record update · 2025-10-06A Phase II Trial of Hypofractionated Radiotherapy in Patients With Limited Progression on Immune Checkpoint Blockade
-
CLINICAL_TRIALS study record update · 2025-10-03HANSE - Holistic Implementation Study Assessing a Northern German Interdisciplinary Lung Cancer Screening Effort, Population-based Screening Study -Prospective, Randomized Comparator Controlled
-
CLINICAL_TRIALS study record update · 2025-10-02ClinicalTrials.gov study NCT00722228
-
CLINICAL_TRIALS study record update · 2025-10-02Clinical Study of CD70-Targeted Chimeric Antigen Receptor T Lymphocytes (CAR-T) in Advanced CD70-Positive Malignant Solid Tumors
-
CLINICAL_TRIALS study record update · 2025-10-02The Effect of 360° Virtual Reality Movies on Fear and Anxiety
-
CLINICAL_TRIALS study record update · 2025-10-02Clinical Study of CEA-Targeted Chimeric Antigen Receptor T Lymphocytes (CAR-T) in Advanced CEA-Positive Malignant Solid Tumors
-
CLINICAL_TRIALS study record update · 2025-10-01Thoracic Radiotherapy Plus Maintenance Durvalumab After First Line Carboplatin and Etoposide Plus Durvalumab in Extensive-stage Disease Small Cell Lung Cancer (ED-SCLC). A Multicenter Single Arm Open Label Phase II Trial.
-
CLINICAL_TRIALS study record update · 2025-10-01Early Detection of Lung Cancer in the Medically Underserved Population
-
CLINICAL_TRIALS study record update · 2025-09-29Sacituzumab Tirumotecan (Sac-TMT) Plus Bevacizumab in 3rd Generation EGFR-TKI Treated Advanced EGFR-mutant Nonsquamous NSCLC With Brain Metastasis: a Single-arm, Phase II Study（TOP BRAIN）
-
CLINICAL_TRIALS study record update · 2025-09-29A Single Arm, Phase 2 Study of Datopotamab Deruxtecan, Carboplatin, and Pembrolizumab for Treatment-naive Brain Metastases From NSCLC (Non-small Cell Lung Cancer)
-
CLINICAL_TRIALS study record update · 2025-09-26Molecular Fingerprinting of Lung Cancer
-
CLINICAL_TRIALS study record update · 2025-09-25Improving Cancer Care by Incorporating the Patient's Voice Into On-treatment Symptom Management